XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,607,998 | -11.8% | 3,003,747 | -0.6% | 0.76% | +29.5% |
| Q2 2023 | $116,349,734 | +7.8% | 3,022,071 | +0.2% | 0.59% | -16.3% |
| Q1 2023 | $107,971,916 | -10.1% | 3,016,818 | -1.0% | 0.70% | -26.8% |
| Q4 2022 | $120,098,812 | +24.9% | 3,045,874 | +14.4% | 0.96% | +56.4% |
| Q3 2022 | $96,124,000 | +24.4% | 2,662,722 | +4.8% | 0.61% | +34.8% |
| Q2 2022 | $77,269,000 | +15.4% | 2,540,059 | +16.0% | 0.45% | +50.3% |
| Q1 2022 | $66,950,000 | +27.0% | 2,190,059 | +29.7% | 0.30% | +52.5% |
| Q4 2021 | $52,734,000 | – | 1,688,044 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |